Alpharma starts roadshow for $200 million seven-year notes

By Paul A. Harris

St. Louis, April 8 - Alpharma Inc. began a roadshow Tuesday for a $200 million offering of senior notes due 2011, according to a syndicate source.

The roadshow is expected to conclude on April 14.

Banc of America Securities is the bookrunner. CIBC World Markets is co-manager.

The Rule 144A notes are non-callable for four years.

Proceeds will be used to repay debt incurred in the acquisition of FH Faulding & Co Ltd.

The issuer is a Fort Lee, N.J.-based specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.